论文部分内容阅读
新兴医院遭受如此口诛笔伐,根源在与老百姓对混乱的医药市场及广告长期累积的不满的爆发式宣泄。新兴医院不巧正好做了一回“出气筒”,也当了一回虚假医疗卫生广告的“榜样”。盛名之下,其实难副。虽然医药行业广告投放连年位居中国各行业广告投放额度前列,但与之对应的是,在今年全国“慧眼识广告”活动近万件消费者投诉中,药品广告位居榜首,占17.5％。在接受“慧眼识广告”调查的3358位消费者中,有60.5％的消费者感到虚假医药广告损害自身权益最为严重。这种强烈的反差不禁令人深思,中国民族医药企业的营销之路为何路越走越窄,除了弄虚作假,坑蒙拐骗,就是广告
Emerging hospitals have suffered so many vocal oppositions, rooted in explosive outbursts of discontent with long-term accumulation of people’s confusion in the pharmaceutical market and advertising. Emerging hospitals happened to be doing a “punching bag”, but also when a false medical and health ads “role model.” Under the well-known, in fact, difficult to associate. Although the advertising of the pharmaceutical industry ranks the forefront of advertising spending in various industries in China in recent years, among the nearly 10,000 consumer complaints in this year’s “Eye-catching Advertising Campaign”, pharmaceutical advertisements topped the list, accounting for 17.5% of the total. Of the 3,358 consumers surveyed, 55.5 percent of consumers feel that false medical advertisements hurt their own rights and interests the most. This strong contrast can not help but think about why the marketing path of Chinese national pharmaceutical companies is getting narrower and narrower, in addition to fraud, swindling, is advertising